肝がんの世界市場レポート 2025年

肝がん市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR14.3％で57億5,000万米ドルに成長します。予測期間中の成長は、高齢者人口の拡大、ヘルスケア支出の増加、低侵襲治療に対する需要の増加、専門クリニックの増加、医療ツーリズムの成長に起因しています。この期間の主な動向としては、診断技術の発展、標的療法の開発、併用療法の導入、外科手術の技術革新、放射線治療技術の進歩などが挙げられます。

アルコールの消費量の増加が肝がん市場の拡大を牽引すると予想されます。アルコールの消費量は、その量と頻度によって測定されるのが一般的であるが、メディアで宣伝され、さまざまな場面で入手しやすくなったことで、人々が日々のストレスを解消し、社会的交流を促進し、リラックス効果を高めるのに役立っているため、増加の一途をたどっています。しかし、アルコールの過剰摂取は、肝硬変や炎症、DNAの損傷を引き起こし、細胞の異常増殖を促すことで肝がんのリスクを高めます。例えば、2023年3月、アイルランドを拠点とするデータ収集機関National Drugs Libraryは、15歳以上の個人の平均アルコール消費量が2022年には1人当たり純アルコール10.2リットルに増加し、2021年から7.6％増加したと報告しました。このアルコール消費量の増加が肝がん市場の成長に寄与しています。

肝がん市場の主要企業は、治療精度の向上、患者の転帰の改善、副作用の軽減を目指し、先進治療機器、特に経カテーテル的動脈化学塞栓療法（TACE）の開発に注力しています。TACEは、治療効果を高めるために血液供給を遮断しながら化学療法を肝腫瘍に直接投与する低侵襲手術です。例えば、日本の医療技術企業であるテルモ株式会社は、2023年11月、肝がんの管理を支援する2つの革新的な治療機器、OcclusafeとLifePearlを発売しました。これらの機器は、インドで最も一般的な原発性肝がんである肝細胞がん（HCC）の治療を改善するために設計されており、毎年2万人以上の新規患者が発生しています。Occlusafeは、Balloon-TACE（B-TACE）として知られる最先端の治療法の一部であり、手技中にバルーンを使用して血流を遮断することにより、TACEの精度と効果を高める。ライフパールはポリエチレングリコール（PEG）塞栓微小球からなり、化学療法剤を充填することができます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の肝がんPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の肝がん市場：成長率分析
• 世界の肝がん市場の実績：規模と成長、2019年～2024年
• 世界の肝がん市場の予測：規模と成長、2024年～2029年、2034年
• 世界の肝がん総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の肝がん市場：タイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 肝芽腫
• 肝内胆管がん
• 肝細胞がん
• 線維層がん
• 世界の肝がん市場：肝がんのステージ別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 早期
• 中級ステージ
• 上級段階
• 世界の肝がん市場：治療別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 標的療法
• 放射線治療
• 手術
• 化学療法
• 免疫療法
• 世界の肝がん市場：エンドユーザー別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 病院
• 専門クリニック
• 外来手術センター
• がん調査機関
• 世界の肝がん市場、肝芽腫の種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• 上皮性肝芽腫
• 上皮性・間葉性混合肝芽腫
• 世界の肝がん市場、肝内胆管がんの種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• 腫瘤形成性胆管がん
• 胆管周囲浸潤性胆管がん
• 胆管内増殖性胆管がん
• 世界の肝がん市場、肝細胞がんの種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• 線維層状肝細胞がん
• 従来の肝細胞がん
• スキルス肝細胞がん
• 明細胞肝細胞がん
• リンパ上皮腫様肝細胞がん
• 世界の肝がん市場、線維層がんの種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• 古典的線維層がん
• 混合線維層状肝細胞がんと通常型肝細胞がん

第7章 地域別・国別分析

• 世界の肝がん市場：地域別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 世界の肝がん市場：国別、実績と予測、2019年～2024年、2024年～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 肝がん市場：競合情勢
• 肝がん市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sanofi S.A.
• Bristol-Myers Squibb Company
• Thermo Fisher Scientific Inc.
• AstraZeneca PLC
• Abbott Laboratories
• Novartis AG
• Eli Lilly and Company
• Siemens Healthineers AG
• Terumo Corporation
• Eisai Co. Ltd.
• Qiagen N.V.
• Exelixis Inc.
• BeiGene Ltd.
• RayzeBio Inc.
• Innovent Biologics Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 肝がん市場2029年：新たな機会を提供する国
• 肝がん市場2029年：新たな機会を提供するセグメント
• 肝がん市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Liver cancer is a type of malignant disease that begins in the liver cells, primarily hepatocytes, and has the potential to spread to other organs. It is linked to risk factors such as chronic infections with hepatitis B and C, cirrhosis, excessive alcohol use, and non-alcoholic fatty liver disease (NAFLD). The disease is often diagnosed in its advanced stages, making early detection and treatment essential for improving survival rates.

The main forms of liver cancer include hepatoblastoma, intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and fibrolamellar carcinoma. Hepatoblastoma is a rare form of liver cancer that typically affects young children and arises from immature liver cells. Liver cancer progresses through various stages, including the early, intermediate, and advanced stages. Treatment options include targeted therapy, radiation therapy, surgery, chemotherapy, and immunotherapy. The primary end users of these treatments are hospitals, specialty clinics, ambulatory surgical centers, and cancer research institutes.

The liver cancer market research report is one of a series of new reports from The Business Research Company that provides liver cancer market statistics, including the liver cancer industry global market size, regional shares, competitors with the liver cancer market share, detailed liver cancer market segments, market trends, and opportunities, and any further data you may need to thrive in the liver cancer industry. This liver cancer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The liver cancer market size has grown rapidly in recent years. It will grow from $2.94 billion in 2024 to $3.37 billion in 2025 at a compound annual growth rate (CAGR) of 14.5%. The growth during the historic period can be attributed to the increasing global incidence of liver cancer, the rising prevalence of hepatitis B and C infections, higher rates of non-alcoholic fatty liver disease, government initiatives encouraging early diagnosis, and growing awareness about liver health.

The liver cancer market size is expected to see rapid growth in the next few years. It will grow to $5.75 billion in 2029 at a compound annual growth rate (CAGR) of 14.3%. The growth during the forecast period can be attributed to the expanding geriatric population, higher healthcare spending, increasing demand for minimally invasive treatments, a rise in specialty clinics, and the growth of medical tourism. Key trends during this period include advancements in diagnostic technologies, the development of targeted therapies, the introduction of combination therapies, technological innovations in surgical procedures, and progress in radiotherapy techniques.

The growing consumption of alcohol is expected to drive the expansion of the liver cancer market. Alcohol consumption, typically measured by its quantity and frequency, has been rising as it helps people relieve daily stress, fosters social interaction, and enhances relaxation, with its promotion in media and increased accessibility in various settings. However, excessive alcohol intake can lead to liver cirrhosis, inflammation, and DNA damage, which increases the risk of liver cancer by encouraging abnormal cell growth. For example, in March 2023, the National Drugs Library, an Ireland-based data collection organization, reported that the average alcohol consumption for individuals aged 15 and older increased to 10.2 liters of pure alcohol per capita in 2022, reflecting a 7.6% rise from 2021. This increase in alcohol consumption is contributing to the growth of the liver cancer market.

Leading companies in the liver cancer market are focusing on developing advanced therapy devices, specifically transcatheter arterial chemoembolization (TACE), to improve treatment precision, patient outcomes, and reduce side effects. TACE is a minimally invasive procedure that delivers chemotherapy directly to a liver tumor while blocking its blood supply to increase the treatment's effectiveness. For example, in November 2023, Terumo Corporation, a Japan-based medical technology company, launched two innovative therapy devices, Occlusafe and LifePearl, to assist in the management of liver cancer. These devices are designed to improve the treatment of hepatocellular carcinoma (HCC), the most common type of primary liver cancer in India, which sees over 20,000 new cases each year. Occlusafe is part of a cutting-edge therapy known as Balloon-TACE (B-TACE), which increases the precision and effectiveness of TACE by using a balloon to block blood flow during the procedure. LifePearl consists of polyethylene glycol (PEG) embolization microspheres, which can be loaded with chemotherapeutic agents.

In August 2023, TriSalus Life Sciences, a U.S.-based medical technology company focused on oncology, merged with MedTech Acquisition Corporation. This merger is intended to strengthen TriSalus Life Sciences' financial position and support the development of innovative treatments for liver and pancreatic tumors. MedTech Acquisition Corporation is a special purpose acquisition company (SPAC) that targets mergers with existing medical technology firms.

Major players in the liver cancer market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca PLC, Abbott Laboratories, Novartis AG, Eli Lilly and Company, Siemens Healthineers AG, Terumo Corporation, Eisai Co. Ltd., Qiagen N.V., Exelixis Inc., BeiGene Ltd., RayzeBio Inc., Innovent Biologics Inc., Celsion Corporation.

North America was the largest region in the liver cancer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in liver cancer report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the liver cancer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The liver cancer market consists of revenues earned by entities providing services such as early screening, palliative care, liver transplantation, personalized medicine, and radiofrequency ablation. The market value includes the value of related goods sold by the service provider or included within the service offering. The liver cancer market also includes sales of diagnostic imaging equipment, biomarker tests, embolization devices, and supportive care medications. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Liver Cancer Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on liver cancer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for liver cancer ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The liver cancer market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Hepatoblastoma; Intrahepatic Cholangiocarcinoma; Hepatocellular Carcinoma; Fibrolamellar Carcinoma
• 2) By Stage Of Liver Cancer: Early Stage; Intermediate Stage; Advanced Stage
• 3) By Treatment: Targeted Therapy; Radiation Therapy; Surgery; Chemotherapy; Immunotherapy
• 4) By End User: Hospitals; Specialty Clinics; Ambulatory Surgical Centers; Cancer Research Institutes
• Sub Segments:
• 1) By Hepatoblastoma: Epithelial Hepatoblastoma; Mixed Epithelial and Mesenchymal Hepatoblastoma
• 2) By Intrahepatic Cholangiocarcinoma: Mass-forming Cholangiocarcinoma; Periductal Infiltrating Cholangiocarcinoma; Intraductal Growing Cholangiocarcinoma
• 3) By Hepatocellular Carcinoma: Fibrolamellar Hepatocellular Carcinoma; Conventional Hepatocellular Carcinoma; Scirrhous Hepatocellular Carcinoma; Clear Cell Hepatocellular Carcinoma; Lymphoepithelioma-like Hepatocellular Carcinoma
• 4) By Fibrolamellar Carcinoma: Classic Fibrolamellar Carcinoma; Mixed Fibrolamellar and Conventional Hepatocellular Carcinoma
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Bayer AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Liver Cancer Market Characteristics

3. Liver Cancer Market Trends And Strategies

4. Liver Cancer Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Liver Cancer Growth Analysis And Strategic Analysis Framework

• 5.1. Global Liver Cancer PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Liver Cancer Market Growth Rate Analysis
• 5.4. Global Liver Cancer Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Liver Cancer Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Liver Cancer Total Addressable Market (TAM)

6. Liver Cancer Market Segmentation

• 6.1. Global Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hepatoblastoma
• Intrahepatic Cholangiocarcinoma
• Hepatocellular Carcinoma
• Fibrolamellar Carcinoma
• 6.2. Global Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Early Stage
• Intermediate Stage
• Advanced Stage
• 6.3. Global Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Targeted Therapy
• Radiation Therapy
• Surgery
• Chemotherapy
• Immunotherapy
• 6.4. Global Liver Cancer Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Cancer Research Institutes
• 6.5. Global Liver Cancer Market, Sub-Segmentation Of Hepatoblastoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Epithelial Hepatoblastoma
• Mixed Epithelial and Mesenchymal Hepatoblastoma
• 6.6. Global Liver Cancer Market, Sub-Segmentation Of Intrahepatic Cholangiocarcinoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mass-forming Cholangiocarcinoma
• Periductal Infiltrating Cholangiocarcinoma
• Intraductal Growing Cholangiocarcinoma
• 6.7. Global Liver Cancer Market, Sub-Segmentation Of Hepatocellular Carcinoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fibrolamellar Hepatocellular Carcinoma
• Conventional Hepatocellular Carcinoma
• Scirrhous Hepatocellular Carcinoma
• Clear Cell Hepatocellular Carcinoma
• Lymphoepithelioma-like Hepatocellular Carcinoma
• 6.8. Global Liver Cancer Market, Sub-Segmentation Of Fibrolamellar Carcinoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Classic Fibrolamellar Carcinoma
• Mixed Fibrolamellar and Conventional Hepatocellular Carcinoma

7. Liver Cancer Market Regional And Country Analysis

• 7.1. Global Liver Cancer Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Liver Cancer Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Liver Cancer Market

• 8.1. Asia-Pacific Liver Cancer Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Liver Cancer Market

• 9.1. China Liver Cancer Market Overview
• 9.2. China Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Liver Cancer Market

• 10.1. India Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Liver Cancer Market

• 11.1. Japan Liver Cancer Market Overview
• 11.2. Japan Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Liver Cancer Market

• 12.1. Australia Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Liver Cancer Market

• 13.1. Indonesia Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Liver Cancer Market

• 14.1. South Korea Liver Cancer Market Overview
• 14.2. South Korea Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Liver Cancer Market

• 15.1. Western Europe Liver Cancer Market Overview
• 15.2. Western Europe Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Liver Cancer Market

• 16.1. UK Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Liver Cancer Market

• 17.1. Germany Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Liver Cancer Market

• 18.1. France Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Liver Cancer Market

• 19.1. Italy Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Liver Cancer Market

• 20.1. Spain Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Liver Cancer Market

• 21.1. Eastern Europe Liver Cancer Market Overview
• 21.2. Eastern Europe Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Liver Cancer Market

• 22.1. Russia Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Liver Cancer Market

• 23.1. North America Liver Cancer Market Overview
• 23.2. North America Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Liver Cancer Market

• 24.1. USA Liver Cancer Market Overview
• 24.2. USA Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Liver Cancer Market

• 25.1. Canada Liver Cancer Market Overview
• 25.2. Canada Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Liver Cancer Market

• 26.1. South America Liver Cancer Market Overview
• 26.2. South America Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Liver Cancer Market

• 27.1. Brazil Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Liver Cancer Market

• 28.1. Middle East Liver Cancer Market Overview
• 28.2. Middle East Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Liver Cancer Market

• 29.1. Africa Liver Cancer Market Overview
• 29.2. Africa Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Liver Cancer Market Competitive Landscape And Company Profiles

• 30.1. Liver Cancer Market Competitive Landscape
• 30.2. Liver Cancer Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Liver Cancer Market Other Major And Innovative Companies

• 31.1. Sanofi S.A.
• 31.2. Bristol-Myers Squibb Company
• 31.3. Thermo Fisher Scientific Inc.
• 31.4. AstraZeneca PLC
• 31.5. Abbott Laboratories
• 31.6. Novartis AG
• 31.7. Eli Lilly and Company
• 31.8. Siemens Healthineers AG
• 31.9. Terumo Corporation
• 31.10. Eisai Co. Ltd.
• 31.11. Qiagen N.V.
• 31.12. Exelixis Inc.
• 31.13. BeiGene Ltd.
• 31.14. RayzeBio Inc.
• 31.15. Innovent Biologics Inc.

32. Global Liver Cancer Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Liver Cancer Market

34. Recent Developments In The Liver Cancer Market

35. Liver Cancer Market High Potential Countries, Segments and Strategies

• 35.1 Liver Cancer Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Liver Cancer Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Liver Cancer Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer